TVRD
Tvardi Therapeutics, Inc.
1.30$
-3.8%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | -83.0% | +81.8% | -49.9% | -66.0% | -100.0% | |
| – | – | +383.5% | -14.4% | -87.4% | -88.3% | |
| – | – | +60.0% | -57.7% | -56.5% | -101.5% | |
| – | -23.4% | +11.1% | +18.1% | -69.8% | -45.0% | |
| – | – | – | +2.6% | +59.2% | +96.0% | |
| – | -14.1% | +10.2% | +11.6% | -54.3% | -56.9% | |
| – | -1,754.3% | – | – | – | – | |
| – | – | – | -100.0% | – | – | |
| – | -1,245.8% | – | – | – | – | |
| – | – | – | – | – | – | |
| – | -1,151.6% | – | – | – | – | |
| – | -1,094.8% | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.